Skip to main content
Overview
Investor news
Pipeline
Innovative Medicine pipeline
Development pipeline
Novel therapies
2026 Key events
Patent table
Financials
Quarterly results
Annual reports
SEC filings
Investor fact sheet
Events & presentations
Stock info
Stock quote
Stock chart
Historical stock quote
Investment calculator
Dividend history
Stock split information
Governance
Corporate governance overview
2026 Annual Meeting of Shareholders
Board of Directors
Executive Committee
ESG resources
2025 Health for Humanity Report
2024 Janssen Transparency Report
Resources
Investor FAQs
Information request form
Investor email alerts
Investor contacts
Skip to main content
Latest news
Our company
Careers
Investors
Media center
Discover J&J
Medicines & therapies
Medical devices & technology
News
Careers
Contact
Discover J&J
Discover J&J
Discover J&J
Medicines & therapies
Medical devices & technology
News
Careers
Contact
Event Details
Overview
Investor news
Pipeline
Innovative Medicine pipeline
Development pipeline
Novel therapies
2026 Key events
Patent table
Financials
Quarterly results
Annual reports
SEC filings
Investor fact sheet
Events & presentations
Stock info
Stock quote
Stock chart
Historical stock quote
Investment calculator
Dividend history
Stock split information
Governance
Corporate governance overview
2026 Annual Meeting of Shareholders
Board of Directors
Executive Committee
ESG resources
2025 Health for Humanity Report
2024 Janssen Transparency Report
Resources
Investor FAQs
Information request form
Investor email alerts
Investor contacts
Updated Johnson & Johnson Financials and 2023 Guidance
Aug 30, 2023 10:15 AM ET
Webcast
(opens in new window)
Guidance Press Release & Recast Supplemental Schedules
(opens in new window)
Guidance Presentation
(opens in new window)
Recast Other Financial Disclosures (PDF)
(opens in new window)
Recast Other Financial Disclosures (Excel)
(opens in new window)
Transcript
(opens in new window)
Questions? Please contact us:
1-800-950-5089
investor-relations@its.jnj.com